Search Within

William Douglas Tap

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (42)
  2. Meeting Abstract (37)
  3. Research Letter (1)
Groups
  1. Department of Medicine (80)
  2. Epidemiology and Biostatistics (80)
  3. Sarcoma Service (80)
  4. Solid Tumor Oncology Division (80)
  5. Biostatistics Service (72)
  6. GSK Faculty (69)

More Groups

People
  1. Mark Dickson (61)
  2. Li-Xuan Qin (59)
  3. Sandra D'Angelo (59)
  4. Mary Keohan (55)
  5. Mrinal Gounder (54)
  6. Ping Chi (46)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Clinical Cancer Research (8)
  3. Annals of Oncology (5)
  4. European Journal of Cancer (3)
  5. The Oncologist (3)
  6. JAMA Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. American Association for Cancer Research (11)
  3. Oxford University Press (8)
  4. Elsevier Inc. (6)
  5. Nature Publishing Group (6)
  6. Springer (3)

More Publishers

Results (80)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Gundem, G.; Ossa, J. E. A.; Bouvier, N.; Dela Cruz, F. S.; Hameed, M.; Bender, J. L. G.; Tap, W. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Stereotactic body radiotherapy for sarcoma pulmonary metastases
    Meeting Abstract

    Lebow, E. S.; Lobaugh, S.; Zhang, Z.; Dickson, M.; Thornton, K.; Rosenbaum, E.; D'Angelo, S.; Nacev, B.; Shepherd, A. F.; Shaverdian, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
    Journal Article

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S. A.; Antonescu, C. R.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N. D.; Rana, S.; Zehir, A.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase Ib/II randomized study of RO4929097, a gamma-secretase or notch inhibitor with or without vismodegib, a hedgehog inhibitor, in advanced sarcoma
    Journal Article

    Gounder, M. M.; Rosenbaum, E.; Wu, N.; Dickson, M. A.; Sheikh, T. N.; D'Angelo, S. P.; Chi, P.; Keohan, M. L.; Erinjeri, J. P.; Antonescu, C. R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save